Sanofi SA (SNY) News| Reuters.com
Edition:
United States

Sanofi SA (SNY)

SNY on New York Consolidated

41.85USD
30 Jun 2016
Change (% chg)

$0.59 (+1.43%)
Prev Close
$41.26
Open
$41.22
Day's High
$41.94
Day's Low
$41.06
Volume
3,386,768
Avg. Vol
2,114,882
52-wk High
$54.98
52-wk Low
$37.41

Select another date:

Tue, Jun 28 2016

BRIEF-Sanofi sounding out Medivation shareholders as it prepares to raise bid- CNBC

* Sanofi sounding out Medivation shareholders as it prepares to raise bid- CNBC (Bengaluru Newsroom: +1 646 223 8780)

BRIEF-Icagen acquires Sanofi's Oro Valley, Arizona research facility

* Icagen says will retain majority of scientists working at Tucson site in transition

Glass Lewis urges Medivation shareholders to support current board

Medivation Inc said shareholder advisory firm Glass Lewis & Co has recommended the cancer drug maker's stockholders to not support Sanofi SA's efforts to replace the company's board members.

Glass Lewis urges Medivation shareholders to support current board

June 24 Medivation Inc said shareholder advisory firm Glass Lewis & Co has recommended the cancer drug maker's stockholders to not support Sanofi SA's efforts to replace the company's board members.

BRIEF-Sanofi announces expiration of Hart-Scott-Rodino waiting period for proposed acquisition of Medivation

* Sanofi announces expiration of hart-scott-rodino waiting period regarding proposed acquisition of medivation Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

CORRECTED-UPDATE 1-Sanofi, Medivation advance to next phase of takeover fight

NEW YORK, June 13 French drugmaker Sanofi and its takeover target Medivation Inc on Monday said they had filed official materials with the U.S. Securities and Exchange Commission, as their $9.3 billion battle advances to the next phase.

Sanofi files request to replace Medivation board

PARIS French drugmaker Sanofi said on Monday that it had filed a request with U.S. authorities to remove the board of Medivation and replace it with eight independent candidates as it seeks to acquire the cancer drug company.

Sanofi files request to replace Medivation board

PARIS, June 13 French drugmaker Sanofi said on Monday that it had filed a request with U.S. authorities to remove the board of Medivation and replace it with eight independent candidates as it seeks to acquire the cancer drug company.

BRIEF-Sanofi announces positive Phase 3 results

* Announced on Sunday positive Phase 3 results for investigational titratable fixed-ratio combination of insulin glargine and lixisenatide

Sanofi hopes to oust Medivation's board by August 1

PARIS Sanofi said on Wednesday it aims to remove the board of takeover target Medivation by Aug. 1 at the latest.

Select another date: